Skip Content
You are currently on the new version of our website. Access the old version .

Sclerosis, Volume 3, Issue 1

2025 March - 8 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (8)

  • Feature Paper
  • Review
  • Open Access
6 Citations
4,378 Views
28 Pages

Microbial Influences on Amyotrophic Lateral Sclerosis: The Gut–Brain Axis and Therapeutic Potential of Microbiota Modulation

  • Victòria Ayala,
  • Laia Fontdevila,
  • Santiago Rico-Rios,
  • Mònica Povedano,
  • Pol Andrés-Benito,
  • Pascual Torres,
  • José C. E. Serrano,
  • Reinald Pamplona and
  • Manuel Portero-Otin

Background/Objectives: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the progressive degeneration of motor neurons. The gut microbiota, a community of microorganisms in the digestive tract, has recently been imp...

  • Article
  • Open Access
1,606 Views
16 Pages

Uncovering Subclinical Cardiac Involvement in VEDOSS: An Echocardiographic Driven Study

  • Eugenio Capparelli,
  • Eleonora Zaccara,
  • Ilaria Suardi,
  • Antonella Laria,
  • Laura Castelnovo,
  • Eleonora Mauric,
  • Daniela Bompane,
  • Antonio Tamburello,
  • Maria Iacovantuono and
  • Paola Faggioli
  • + 2 authors

25 February 2025

Background: The 2011 Very Early Diagnosis of Systemic Sclerosis (VEDOSS) criteria include both patients at risk of progression and those with mild non-progressive forms of SSc. Early diastolic and systolic dysfunction can indicate myocardial fibrosis...

  • Review
  • Open Access
5,396 Views
23 Pages

Apolipoprotein L1 (APOL1) genetic variations, notably the G1 and G2 alleles, have important roles in the pathophysiology of focal segmental glomerulosclerosis (FSGS) and other kidney problems, especially in people of African descent. This review summ...

  • Review
  • Open Access
4 Citations
5,031 Views
10 Pages

B-Cell-Depleting Immune Therapies as Potential New Treatment Options for Systemic Sclerosis

  • Gerhard Zugmaier,
  • Matthias Klinger,
  • Marion Subklewe,
  • Faraz Zaman and
  • Franco Locatelli

Background: Systemic sclerosis (SSc), also known as scleroderma, is a complex, chronic autoimmune disease characterized by fibrosis of the skin and internal organs, vasculopathy, and immune system dysregulation. The treatment of SSc has historically...

  • Systematic Review
  • Open Access
1 Citations
9,386 Views
13 Pages

Background: Multiple sclerosis (MS) is a chronic inflammatory disease characterized by demyelination in the central nervous system (CNS). Despite the availability of interventions for disease exacerbations and symptomatic management, EM remained with...

  • Article
  • Open Access
2 Citations
2,161 Views
15 Pages

Background/Objectives: Footfall placement variability is associated with falls in older adults and neurological diseases. Thus, the study of dual-task gait impairment in middle-aged to older-aged adults with multiple sclerosis (MS) is clinically rele...

  • Systematic Review
  • Open Access
1 Citations
5,778 Views
19 Pages

Efficacy and Immunological Impact of Intrathecal Baclofen Pumps in Managing Spasticity in Multiple Sclerosis in Adult Patients: A Systematic Review

  • Billy McBenedict,
  • Wilhelmina Hauwanga,
  • Anna Pogodina,
  • Jeshua Nathaniel Devan,
  • Kang Suen Goh,
  • Ryan Chun Chien Yau,
  • Berley Alphonse,
  • Lorena Adolphsson and
  • Bruno Lima Pessôa

Background/Objectives: Multiple sclerosis (MS) is a chronic autoimmune disease marked by inflammatory demyelination in the central nervous system, leading to debilitating spasticity. Managing spasticity in MS remains a challenge, and intrathecal bacl...

  • Review
  • Open Access
2,879 Views
13 Pages

High-Fat Diet—Shared Environmental Risk Factor for Amyotrophic Lateral Sclerosis and Multiple Sclerosis

  • Thomas Gabriel Schreiner,
  • Liviu Iacob,
  • Cristina Georgiana Croitoru,
  • Diana Nicoleta Hodorog and
  • Dan Iulian Cuciureanu

Background: Amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) are, in essence, neurodegenerative disorders with significant individual, social, and economic burdens worldwide. Despite having different clinical onset and evolution, the t...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Sclerosis - ISSN 2813-3064